期刊文献+

卒中后痫性发作及卒中后癫痫研究现状与进展 被引量:4

Research Status and Advances of Post-stroke Seizure and Post-stroke Epilepsy
下载PDF
导出
摘要 卒中后痫性发作和卒中后癫痫的定义尚不统一,流行病学研究显示其发生率在卒中患者中为3%~30%,对卒中患者的预后有一定的影响。针对卒中后痫性发作和卒中后癫痫的治疗有卒中的治疗和二级预防以及抗癫痫药物治疗,有的研究显示新型抗癫痫药物的治疗效果优于传统药物,他汀类药物也可能降低其发生率。目前尚缺乏关于卒中后痫性发作和癫痫的诊疗共识或指南,亟待进一步研究为其提供循证医学证据。 Definition of post-stroke seizure and epilepsy remains inconsistent so far. The reported incidence of seizures after ischemic infarction varies greatly from 3% to 30%, which may exert adverse effects on clinical prognosis in stroke patients. The intervention strategies include management of stroke risk factors, stroke recurrence prevention and antiepileptic treatment. Some studies indicated that the effect of new antiepileptic drugs was superior to traditional medications, and statins might also lower the risk of occurrence. For now, there is no definite consensus or guideline for the diagnosis and treatment of post-stroke seizure and epilepsy, which requires further research to provide more evidence-based findings.
作者 郭毅佳 何俐 周东 GUO Yi-Jia HE Li ZHOU Dong(Department of Neurology, West China Hospital Sichuan University, Chengdu 610000, China)
出处 《中国卒中杂志》 2017年第3期251-255,共5页 Chinese Journal of Stroke
关键词 卒中 痫性发作 癫痫 治疗 预后 Stroke Seizure Epilepsy Treatment Prognosis
  • 相关文献

参考文献1

二级参考文献99

  • 1Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 2Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 3Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 4Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 5Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 6Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 7Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 8Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.
  • 9Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032.
  • 10Kwiatkowski TG, Libman RB, Fmnkel M, et al. Effects of tissue plasrrfinogen activator for acute ischemic stroke at one year. National Institute of Neurological Disordeis and Stroke Recombinxaat Tissue Plasmiogen Activator Stroke Study Group. N Engl J Med, 1999, 340: 1781-1787.

共引文献984

同被引文献32

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部